Form 4: VolitionRx CCO's Stock Holdings Update

VolitionRx's Chief Commercial Officer, Gael Forterre, reported a change in beneficial ownership related to tax withholding on restricted stock units.

Summary

• Gael Forterre, Chief Commercial Officer of VolitionRx Ltd (VNRX), reported a change in beneficial ownership.
• On August 1, 2025, 2,766 shares of common stock were disposed of to VolitionRx at a price of $0.64 per share.
• This disposition was to satisfy tax withholding obligations upon the settlement of 6,690 restricted stock units (RSUs) awarded in lieu of cash compensation.
• No shares were sold by Mr. Forterre or VolitionRx in this transaction.
• Following the transaction, Mr. Forterre directly holds 156,700 common shares.
• Indirect holdings include 5,000 shares by his spouse and 32,500 shares by Armorica Partners, LLC, where Mr. Forterre is the managing director.

Sentiment

Score: 5

Explanation: Neutral. The transaction is a routine tax withholding event for restricted stock units, not a discretionary sale by the insider. It reflects a standard compensation practice.

Positives

• The transaction was for tax withholding purposes on restricted stock units, not a direct sale by the officer.
• The restricted stock units were awarded in lieu of cash compensation, indicating a non-cash compensation strategy.

Negatives

• A reduction of 2,766 shares in direct beneficial ownership due to tax withholding.

Future Outlook

No forward-looking statements or guidance are provided in this filing.

Industry Context

This filing details a routine insider transaction related to executive compensation, specifically the tax withholding associated with the vesting of restricted stock units. This type of transaction is common across various industries for publicly traded companies that utilize equity-based compensation.

Comparison to Industry Standards

• This is a routine tax withholding event for RSU vesting, which is a standard practice in executive compensation across most industries.
• The mechanism of shares being retained by the issuer to cover tax obligations is a common method for settling equity awards, comparable to practices at companies like Microsoft, Apple, or Google when their executives' stock options or RSUs vest.

Related Party Transactions

• Disposition of shares by Chief Commercial Officer to the issuer for tax withholding purposes on restricted stock units.
• Indirect beneficial ownership of 32,500 shares through Armorica Partners, LLC, where Mr. Forterre is the managing director and sole shareholder, with a disclaimer of beneficial ownership except for pecuniary interest.

Stakeholder Impact

• Shareholders: Minor, routine adjustment to insider holdings, no direct impact on company operations or financial health.
• Employees: Reflects standard executive compensation practices involving restricted stock units.

Key Dates

Recommendation

The filing details a routine insider transaction related to tax withholding on restricted stock units, not a discretionary sale. This type of transaction is common and does not indicate any significant positive or negative operational or financial developments for the company. Therefore, it provides no new information to warrant a change in investment stance.

Keywords

VolitionRx, VNRX, SEC Form 4, Insider Trading, Stock Ownership, Restricted Stock Units, Tax Withholding, Gael Forterre, Chief Commercial Officer